Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies

Clinical and Experimental Immunology

Volumn 107, Issue 1, 1997, Pages 127-134

  Audrain, M A P ^a,d   Baranger, T A R ^a   Moguilevski, N ^b   Martin, S J ^a   Devys, A ^a   Lockwood, C M ^c   Muller, J Y ^a   Esnault, V L M ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d Laboratoire d'Immunologie   (France)

Author keywords

Anti neutrophil cytoplasmic antibodies; Epitope; Myeloperoxidase; Recombinant; Vasculitis

Indexed keywords

AUTOANTIBODY; EPITOPE; MONOCLONAL ANTIBODY; MYELOPEROXIDASE; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VASCULITIS;

EID: 0031025561     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-895.x     Document Type: Article

References (27)

1. Falk RJ, Hogan SL, Wilkman AS, Terrell RS, Lauritzen S, Charles SA, Jennette JC. Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA). Neth J Med 1990; 36:121-5.
2. Fulk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318:1651-7.
3. Cohen-Tervaert JW, Van Der Woude FJ, Fauci AS et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989; 149:2461-5.
4. Lee SS, Adu D, Thompson RA. Anti-myeloperoxidase antibodies in systemic vasculitis. Clin Exp Immunol 1990; 79:41-46.
5. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus actiology. B Med J 1982; 285:606.
6. Van Der Woude FJ, Rasmussen N, Lobatto S et al. Autoantibodies to neutrophils and monocytes: a new tool for diagnosis and a marker of disease activity in Wegener's granulomatosis. Lancet 1985; ii:425-9.
7. Gross WL, Lüdemann G, Kiefer G, Lehman H. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet 1986; i:806.
8. Venning MC, Arfeen S, Bird G A. Antibodies to neutrophil cytoplasmic antigen in systemic vasculitis. Lancet 1987; ii:850.
9. Lüdemann G, Gross WL. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. Clin Exp Immunol 1987; 69:350-7.
10. Nölle B, Specks U, Lüdemann J, Rohrbach MS, Deremee RA, Gross WL. Anticytoplasmic antibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Int Med 1989; 111:28-40.
11. Chang KS, Trujillo JM, Cook RG, Stass SA. Human myeloperoxidase gene: molecular cloning and expression in leukemic cells. Blood 1986; 68:1411-4.
12. Moguilevsky N, Garcia-Quintana L, Jacquet A, Tournay C, Fabry L, Pierard L, Bollen A. Structural and biological properties of human recombinant myeloperoxidase produced by Chinese hamster ovary cell lines. Eur J Biochem 1991; 197:605-14.
13. Short AK, Moguilevski N, Lockwood CM. Restricted specificity of anti-MPO antibodies in systemic vasculitis: implications for therapy. (Abstr.) Clin Exp Immunol 1995; 101 (Suppl. 1):15.
14. Royal MO, Reisner JC, Jennette JC, Falk RJ. Mapping immunodominant epitopes of myeloperoxidase. (Abstr.) Clin Exp Immunol 1995; 101 (Suppl. 1):7.
15. Audrain MAP, Baranger TAR, Lockwood CM, Esnault VLM. High immunoreactivity of lactoferrin contaminating commercially purified myeloperoxidase. J Immunol Methods 1994; 176:23-31.
16. Audrain MAP, Gourbil A, Muller JY, Esnault VLM. Anti-lactoferrin auto-antibodies: relation between epitopes and iron-binding domain. J Autoimmun; 1996: 9:569-74.
17. Esnault VLM, Jayne DRW, Weetman AP, Lockwood CM. IgG subclass distribution and relative functional affinity of anti-myeloperoxidase antibodies in systemic vasculitis at presentation and during follow-up. Immunology 1991; 74:714.
18. Esnault VLM. Short AK, Audrain MAP, Jones SJ, Martin SJ, Skehel JM. Lockwood CM. Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays. Kidney Int 1994; 46:153-60.
19. Kearney JF, Radbruch A, Liesegang B, Rajewsky K. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 1979; 123:1548.
20. Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldbert ME. Measurements of the true affinity constant in solution of antigen antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 1985; 77:305-19.
21. Nieto A, Gaya A, Jansa M, Moreno C, Vives J. Direct measurement of antibody affinity distribution by hapten-inhibition enzyme immunoassay. Mol Immunol 1984; 21:537-43.
22. Ternynck T, Avrameas S. Murine natural monoclonal autoantibodies: a study of their polyspecificities and their affinities. Immunol Rev 1986; 94:99-112.
23. Kokolina E, Noël LH, Nusbaum P, Geffriaud C, Grünfeld JP, Halbwachs-Mecarelli L, Lesavre Ph. Isotype and affinity of anti-myeloperoxidase autoantibodies in systemic vasculitis. Kidney Int 1994; 46:177-84.
24. Baranger TAR, Audrain MAP, Testa A, Besnier D, Guillevin L, Esnault VLM. Anti-neutrophil cytoplasm antibodies in classical polyarteritis nodosa: help for systemic vasculitis classification? Autoimmunity 1995; 20:33-37.
25. Short AK, Lockwood CM, Bollen A, Moguilevski N. Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis. Clin Exp Immunol 1995; 102:106-11.
26. Cohen-Tervaert JW, Goldschmeding R, Elema JD et al. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 1990; 33:1264-72.
27. Franssen CFM, Gans ROB, Arends B, Hageluken C, Ter Wee PM, Gerlag PGG, Hoorntje SJ. Differences between anti-myeloperoxidase and anti-proteinase 3-associated renal disease. Kidney Int 1995; 47:193-9.